{
    "2020-07-17": [
        [
            {
                "time": "2020-07-17",
                "original_text": "北向资金本周活跃股榜单，逆势青睐19股",
                "features": {
                    "keywords": [
                        "北向资金",
                        "活跃股",
                        "逆势"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "陆港通每周复盘 | 南下资金出逃中芯国际！加仓腾讯、小米",
                "features": {
                    "keywords": [
                        "陆港通",
                        "南下资金",
                        "中芯国际",
                        "腾讯",
                        "小米"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "医药生物2020下半年投资策略：产业升级 关注医药核心价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "产业升级",
                        "核心价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "恒瑞又双叒叕领衔！上半年6279项临床试验登记盘点！",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "临床试验",
                        "医药研发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "仁会生物：专注创新药研发，打破国外药物垄断",
                "features": {
                    "keywords": [
                        "仁会生物",
                        "创新药",
                        "研发",
                        "垄断"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "观察】亏损依旧！东阿阿胶何时走出业绩泥潭？ 亏损",
                "features": {
                    "keywords": [
                        "东阿阿胶",
                        "亏损",
                        "业绩泥潭"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "13家药企市值超千亿！君实生物上半年预亏5亿，现大涨173%！ 预亏",
                "features": {
                    "keywords": [
                        "药企",
                        "市值",
                        "君实生物",
                        "预亏",
                        "大涨"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "看清三大现象，A股中长期行情不悲观",
                "features": {
                    "keywords": [
                        "A股",
                        "中长期",
                        "行情",
                        "不悲观"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "中芯国际上市大涨背后，折射出科创板三个新趋势",
                "features": {
                    "keywords": [
                        "中芯国际",
                        "科创板",
                        "新趋势",
                        "国产替代"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-17",
                "original_text": "非核心矛盾引起的调整往往是配置机会",
                "features": {
                    "keywords": [
                        "非核心矛盾",
                        "调整",
                        "配置机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}